Company
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.
The introduction of artificial intelligence into Medicare's prior authorization process is intended to reduce healthcare fraud and unnecessary medical procedures. However, the early months of the new WISeR program suggest that many patients and healthcare providers are facing unexpected delays, confusion, and administrative burdens instead of a smoother experience.
The Wasteful and Inappropriate Service Reduction (WISeR) Model was launched in January 2026 across six pilot states, including Oklahoma, Arizona, New Jersey, Ohio, Texas, and Washington. The initiative requires prior approval for selected medical procedures that Medicare believes are at higher risk of fraud or overuse.
While officials say the program is designed to improve efficiency and protect both patients and taxpayers, many physicians and patients report that the rollout has introduced new complications into the healthcare system.
The WISeR Model is a Medicare pilot program that uses artificial intelligence to review prior authorization requests before certain medical procedures can be performed.
Unlike traditional Medicare, which historically required very little prior authorization, WISeR applies preapproval requirements to 13 selected medical services. These include treatments such as epidural spinal injections, kyphoplasty for spinal fractures, skin substitute therapies, and several other procedures considered vulnerable to unnecessary use or fraudulent billing.
Healthcare providers submit patient records through an online portal where AI assists in reviewing whether requests meet Medicare's approval criteria. According to Medicare officials, requests that clearly satisfy the guidelines receive rapid approval while more complex cases undergo additional review by clinical professionals.
Although the system promises faster decision making, some Medicare beneficiaries have encountered significant delays.
One Oklahoma patient who regularly receives epidural injections for chronic back pain reported making multiple long-distance trips to his healthcare provider simply because new authorization paperwork was required. Instead of receiving treatment during a scheduled visit, additional appointments became necessary to complete documentation.
For patients living in rural communities, repeated travel can become expensive, time consuming, and physically difficult. Delays in pain management or other essential treatments may also reduce quality of life while waiting for approval.
Several healthcare organizations have reported growing backlogs during the initial months of the program, leaving many patients waiting longer than expected for procedures that previously required no prior authorization.
Many physicians say the new process has increased paperwork and administrative responsibilities.
Medical practices must upload extensive documentation, monitor approval status, respond to additional information requests, and sometimes appeal denied applications. Some providers believe reviewers occasionally overlook documents already submitted, resulting in duplicate requests and further delays.
Doctors also report slower reimbursement for approved procedures. While Medicare indicates that payments should generally be processed within a relatively short timeframe, some healthcare providers have experienced payment delays lasting several weeks.
These challenges have added financial pressure for clinics while increasing workloads for administrative staff responsible for managing insurance approvals.
Artificial intelligence plays a major role in the WISeR review process, although Medicare states that human reviewers make the final authorization decisions.
Despite these assurances, some physicians suspect that AI-generated errors may be contributing to inappropriate denials. In several reported cases, providers believe approval decisions referenced medical information that was either incorrect or inconsistent with patient records.
Technology vendors involved in the program deny widespread AI errors and state that their systems are designed to support clinical decision making rather than replace human judgment.
Even so, the possibility of AI mistakes has raised concerns among healthcare professionals who worry that patients could experience delayed treatment because of inaccurate automated assessments.
Federal officials argue that prior authorization helps reduce unnecessary medical spending while protecting patients from procedures that may not provide meaningful health benefits.
Certain medical services included in the WISeR program have experienced sharp increases in Medicare spending over recent years. Government oversight agencies have identified some of these areas as being vulnerable to fraud, waste, or excessive utilization.
Medicare leaders emphasize that the goal is not to deny appropriate care but to ensure that treatments are medically necessary before taxpayer funds are spent.
Officials also believe AI technology has the potential to speed up approvals when providers submit complete documentation.
Healthcare organizations generally support efforts to reduce fraud but remain concerned about the pace of implementation.
Many provider groups argue that the system was introduced too quickly, leaving little time for physician education, software testing, and workflow adjustments. Technology vendors themselves have acknowledged that certain features continued to evolve even after the program launched.
Some healthcare experts also worry that if the pilot demonstrates cost savings, similar prior authorization requirements could eventually expand to additional Medicare services across the country.
Others caution that any financial savings should be balanced against the added burden placed on patients, physicians, and healthcare staff.
At present, Medicare officials say there are no immediate plans to broaden the list of services included under the WISeR Model. However, the agency continues to evaluate the program's performance and may consider future adjustments based on the results of the pilot.
Healthcare providers will likely continue monitoring how effectively the system balances fraud prevention with timely access to medically necessary care.
The outcome of this pilot could influence how artificial intelligence is used in Medicare and other public healthcare programs in the years ahead.
Artificial intelligence has the potential to improve healthcare administration by reducing fraud and streamlining approval processes. However, the early experience with Medicare's WISeR Model demonstrates that implementing new technology within a complex healthcare system presents significant challenges.
Patients have reported delays in receiving treatment, physicians have faced increased administrative work, and concerns remain regarding the reliability of AI-assisted decision making. As Medicare continues evaluating the pilot program, policymakers will need to ensure that efforts to reduce waste do not unintentionally create barriers to timely patient care.
Finding the right balance between innovation, efficiency, and patient access will be essential as artificial intelligence becomes more integrated into healthcare administration.
KFF Health News.
This article is intended for informational and educational purposes only. It should not be considered medical, legal, or financial advice. Healthcare policies and Medicare regulations may change over time. Always consult qualified healthcare professionals and official Medicare resources for personalized guidance regarding medical treatment, insurance coverage, or healthcare decisions.